Takehiro Tozuka
-
- Cancer Immunotherapy and Biomarkers 17
- Lung Cancer Research Studies 10
- Colorectal Cancer Treatments and Studies 4
- Peptidase Inhibition and Analysis 3
-
- Lung Cancer Treatments and Mutations 18
- Brain Metastases and Treatment 6
- Lung Cancer Diagnosis and Treatment 5
-
- Cancer Genomics and Diagnostics 3
Takehiro Tozuka
32 papers receiving 243 citations
Peers
Comparison fields: 5 of 43
- Oncology 198
- Pulmonary and Respiratory Medicine 156
- Cancer Research 29
- Immunology 23
- Genetics 9
Countries citing papers authored by Takehiro Tozuka
This map shows the geographic impact of Takehiro Tozuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiro Tozuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiro Tozuka more than expected).
Fields of papers citing papers by Takehiro Tozuka
This network shows the impact of papers produced by Takehiro Tozuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiro Tozuka. The network helps show where Takehiro Tozuka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Takehiro Tozuka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 5 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 5 | |
| 13 | 2021 | 2 | |
| 14 | 2021 | 4 | |
| 15 | 2020 | 15 | |
| 16 | 2020 | 22 | |
| 17 | 2019 | 1 | |
| 18 | 2019 | 27 | |
| 19 | 2018 | 9 | |
| 20 | 2018 | 5 |
About Takehiro Tozuka
Takehiro Tozuka is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 33 papers that have together received 249 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Cancer Immunotherapy and Biomarkers (17 papers), Lung Cancer Research Studies (10 papers), Brain Metastases and Treatment (6 papers), Lung Cancer Diagnosis and Treatment (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Peptidase Inhibition and Analysis (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Oncology (198 citations), Pulmonary and Respiratory Medicine (156 citations) and Cancer Research (29 citations). Takehiro Tozuka has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Masahiro Seike, Hiroshi Yoshida, Satoru Kitazono, Ken Uchibori, Noriko Yanagitani, Makoto Nishio, Hiroaki Sakamoto, Akihiko Gemma, Tsukasa Hasegawa and Takahiro Yoshizawa. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.